tiprankstipranks
AstraZeneca PLC (GB:AZN)
LSE:AZN

AstraZeneca Stock Forecast & Price Target

62 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Moderate Buy
12Ratings
8 Buy
4 Hold
0 Sell
Based on 12 analysts giving stock ratings to
AstraZeneca
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AZN Stock Price Prediction

Average Price Target

12,281.82p
▲(23.77% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for AstraZeneca in the last 3 months. The average price target is 12,281.82p with a high forecast of 17,500.00p and a low forecast of 9,800.00p. The average price target represents a 23.77% change from the last price of 9,923.00p.
Highest Price Target17,500pAverage Price Target12,282pLowest Price Target9,800p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Citigroup
13000.00p
Buy
31.01%
Upside
Reiterated
Citi Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)Citi analyst Andrew Baum reiterated a Buy rating and GBP130.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).
UBS
1010.00p
Hold
-89.82%
Downside
Downgraded
Dow Retreats, Oracle Surgesand What Else Is Happening in the Stock Market TodayAstraZeneca (AZN) stock has dropped 1.3% after getting downgraded to Neutral from Buy at UBS.
Danske Bank
13100.00p
Buy
32.02%
Upside
Initiated
AstraZeneca initiated with a Buy at Danske BankAstraZeneca initiated with a Buy at Danske Bank
Goldman Sachs
6950.00p
Sell
-29.96%
Downside
Reiterated
DZ BANK AG
9200.00p
Hold
-7.29%
Downside
Upgraded
AstraZeneca upgraded to Hold from Sell at DZ BankAstraZeneca upgraded to Hold from Sell at DZ Bank
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
VTYXVentyx Biosciences
PRVAPrivia Health Group
RXDXPrometheus Biosciences
IMCRImmunocore Holdings
SKINBeauty Health
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AZN Stock Forecast FAQ

What is GB:AZN’s average 12-month price target, according to analysts?
Based on analyst ratings, AstraZeneca’s 12-month average price target is 12,281.82p.
    What is GB:AZN’s upside potential, based on the analysts’ average price target?
    AstraZeneca has 23.77% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is GB:AZN a Buy, Sell or Hold?
          AstraZeneca has a conensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.
            What is AstraZeneca’s price target?
            The average price target for AstraZeneca is 12,281.82p. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is 17,500.00p ,the lowest forecast is 9,800.00p. The average price target represents 23.77% Increase from the current price of 9,923p.
              What do analysts say about AstraZeneca?
              AstraZeneca’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis